Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinicoeconomics and Outcomes Research : CEOR|July 20, 2017
A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patientsCristina Lucidi, Vincenza Di Gregorio, Giancarlo Ceccarelli, et al.
World Journal of Gastroenterology|August 26, 2014
Changes in nutritional status after liver transplantationMichela Giusto, Barbara Lattanzi, Vincenza Di Gregorio, et al.
World Journal of Gastroenterology|December 11, 2014
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosisValerio Giannelli, Vincenza Di Gregorio, Valerio Iebba, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 20, 2014
The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosisManuela Merli, Cristina Lucidi, Vincenza Di Gregorio, et al.
Metabolic Brain Disease|December 11, 2012
Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective studyManuela Merli, Michela Giusto, Cristina Lucidi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 12, 2018
A low muscle mass increases mortality in compensated cirrhotic patients with sepsisCristina Lucidi, Barbara Lattanzi, Vincenza Di Gregorio, et al.
Plos One|May 22, 2015
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective surveyManuela Merli, Cristina Lucidi, Vincenza Di Gregorio, et al.
Journal of Hepatology|March 26, 2013
Increased risk of cognitive impairment in cirrhotic patients with bacterial infectionsManuela Merli, Cristina Lucidi, Ilaria Pentassuglio, et al.
Hepatology (Baltimore, Md.)|November 4, 2015
An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trialManuela Merli, Cristina Lucidi, Vincenza Di Gregorio, et al.
Scientific Reports|May 31, 2018
Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathyValerio Iebba, Francesca Guerrieri, Vincenza Di Gregorio, et al.
Pageof 2